Application of MT3 in the Development and Immunogenicity Evaluation of GnRH Vaccines
Zhang, G.; Xu, Y.; Zhu, Y.; Wu, C.; Yin, Y.
Show abstract
Research on immune castration vaccines is of great significance for animal management. In this study, five copies of GnRH were linked to two MT3s by a flexible linker, GGGGS, to construct a recombinant plasmid, pET30a-GnRH5-MT3, which was expressed and purified using E. coli BL21(DE3) cells. The recombinant protein was best expressed under the induction conditions of 25 with 0.25 mM IPTG, with a purity of up to 80% after purification. It was mixed with the external adjuvant ISA 206 and immunized mice by subcutaneous injection. Serum levels of GnRH-specific Antibody, T, FSH and LH were detected by ELISA, and testicular tissue morphology was observed by HE staining. The results showed that GnRH5-MT3 recombinant protein combined with external adjuvant could efficiently induce GnRH-specific antibody production in male mice (P < 0.01-0.001) and significantly reduce the Serum LH, FSH and T concentrations (P < 0.01-0.001). The immunized mice had sparse cells in the seminiferous tubules of the testis, significantly reduced cells at various developmental stages, and almost no mature spermatozoa. This study provides experimental basis for further application of the vaccine in animal immune castration.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- In silico analysis and in planta production of recombinant ccl21/IL1β protein and characterization of its in vitro anti-tumor and immunogenic activity 95%
- Design of multi-epitope vaccine candidate against Brucella type IV secretion system (T4SS) 94%
- Improving germline transmission efficiency in chimeric chickens using a multi-stage injection approach 94%
Similar papers in this journal
- Trivalent mRNA vaccine-candidate against seasonal flu with cross-specific humoral immune response 93%
- Omicron booster in ancestral strain vaccinated mice augments protective immunities against both the Delta and Omicron variants 93%
- Peptides derived of kunitz-type serine protease inhibitor as potential vaccine against experimental schistosomiasis 93%
Similar papers in this journal
- Novel Peptide Inhibitor of Human Tumor Necrosis Factor-α has Antiarthritic Activity 95%
- Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19 95%
- Gamma-irradiated SARS-CoV-2 vaccine candidate, OZG-38.61.3, confers protection from SARS-CoV-2 challenge in human ACEII-transgenic mice 95%
Similar papers in this journal
- Recombinant SARS-CoV-2 RBD molecule with a T helper epitope as a built in adjuvant induces strong neutralization antibody response 96%
- Recombinant SARS-CoV-2 spike S1-Fc fusion protein induced high levels of neutralizing responses in nonhuman primates 96%
- Immunogenic Potential of DNA Vaccine candidate, ZyCoV-D against SARS-CoV-2 in Animal Models 95%
Similar papers in this journal
- A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants 94%
- The protective roles of Eugenol on type 1 diabetes mellitus through NRF2 mediated oxidative stress pathway 92%
- Mesenchymal stem cell suppresses the efficacy of CAR-T toward killing lymphoma cells by modulating the microenvironment through stanniocalcin-1 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.